CoDa Therapeutics codathx.com


Public list: BIO 2016 (619) Pharma Startups (4732)

CoDa Therapeutics is a clinical stage biotechnology company focused on developing targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is developing a new field of science known as gap junction modulation, using a new class of therapeutics that can modulate wound responses and reduce inflammation. CoDa has two open INDs and has completed multiple Phase 1 and Phase 2 trials in both skin and eye, including Investigator-Initiated st...Show all

CoDa Therapeutics is a clinical stage biotechnology company focused on developing targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is developing a new field of science known as ga...Show all

Company (Alive / Active)

Phone: 858-210-7920

Fax:

12520 High Bluff Drive
Suite 350
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CoDa Therapeutics $70.7M Jun 15, 2016
See all 34 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CoDa Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

BioMimetic Therapeutics

Franklin, Tennessee, United States
AcquiredBioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Company's lead technologies are for the healing and restoration of bone and other tissues. Its lead products are based on recombinant human platelet-derived growth factor BB (rhPDGF-BB). In March 2013, BioMimetic Therapeutics was acquired by Wright Medical Group. The valuation of BioMimetic Therapeuti...Show allLogin to see details

AkaRx

Paramus, New Jersey, United States
Alive / ActiveAkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.Login to see details
See all 34 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Wound healing compositions and treatments Mar 21, 2016 Apr 10, 2018 Patent
Formulations comprising antisense nucleotides to connexins Nov 24, 2015 Apr 03, 2018 Patent
Treatment of fibrotic conditions Mar 09, 2015 Aug 22, 2017 Patent
Impaired wound healing compositions and treatments May 11, 2015 May 02, 2017 Patent
Medical devices May 18, 2015 Feb 07, 2017 Patent
See all 35 patents